Moxidectin in Dogs & Cats
Generic: Moxidectin
Moxidectin is a potent macrocyclic lactone endectocide used primarily in veterinary medicine to prevent heartworm disease and control various internal and external parasites in dogs, cats, and horses.
This medication is intended for dogs and cats.
Overview
Moxidectin belongs to the milbemycin class of macrocyclic lactones, which are derived from the fermentation of Streptomyces bacteria. Unlike some older anti-parasitic agents such as Piperazine or Morantel, moxidectin exhibits a higher lipophilicity and a longer half-life, allowing for extended duration of action in the host’s tissues. Clinically, it is recognized for its broad-spectrum efficacy, targeting both adult and larval stages of numerous parasites. It is a critical component of preventative protocols, often formulated as part of Imidacloprid-Moxidectin for topical parasite control, effectively replacing or supplementing older drugs like Oxibendazole in modern therapeutic regimens. Furthermore, because it does not share the same mechanism of action as compounds like Lufenuron, it is frequently utilized in rotation or combination therapy to mitigate the risk of parasite resistance. Veterinarians prescribe moxidectin as a cornerstone of heartworm prophylaxis, ensuring that microfilariae are eliminated before they can mature. While other treatments like Epsiprantel focus on tapeworms, moxidectin’s structural properties allow it to penetrate deeply into the sebaceous glands and systemic circulation, providing robust defense against diverse threats including mites and nematodes.
What It Treats
- Heartworm Disease: Prevents Dirofilaria immitis larvae from maturing into adult heartworms in dogs and cats.
- Hookworms: Treats and controls Ancylostoma caninum and Uncinaria stenocephala infections.
- Roundworms: Targets Toxocara canis and Toxascaris leonina intestinal parasites.
- Whipworms: Effective against Trichuris vulpis which reside in the cecum of dogs.
- Mites and Mange: Used in specific formulations to manage Sarcoptes scabiei and Demodex species.
- Fleas and Ticks: When combined with other agents, it provides synergistic coverage against ectoparasites.
How It Works
Moxidectin functions by binding with high affinity to glutamate-gated chloride channels in the nerve and muscle cells of parasites. By opening these channels, the drug causes an influx of chloride ions, leading to hyperpolarization of the cell membranes. This process results in the paralysis and subsequent death of the parasite, as it loses its ability to coordinate movement or feed effectively. Because mammalian hosts utilize different receptors—specifically GABA-gated chloride channels found primarily in the central nervous system—the drug typically has a high margin of safety for pets, provided the blood-brain barrier remains intact. This selective toxicity allows for systemic clearance of parasites without impacting the host's physiological functions at recommended therapeutic dosages.
Dosage
Dosage is strictly dictated by the animal's weight, species, and the specific formulation (oral, injectable, or topical). Always adhere strictly to the prescription label provided by your veterinarian, as macrocyclic lactones can reach toxic levels in sensitive animals.
Administration
The administration method varies significantly by product formulation. Topical solutions are typically applied to the skin at the base of the neck to prevent ingestion. Oral tablets or chewables should be given with or without food as specified on the package, while injectable forms must be administered exclusively by veterinary professionals under strict aseptic conditions. Never split tablets or use products designed for large animals on smaller pets, as this frequently leads to fatal overdosing.
Storage
Store in a cool, dry place, away from direct sunlight and moisture. Ensure the medication is kept in its original, child-proof packaging and is strictly inaccessible to children and other pets. Check the expiration date regularly and do not use if the seal has been tampered with or if the product has been subjected to extreme temperature fluctuations.
Contraindications
Moxidectin is strictly contraindicated in animals with known hypersensitivity to macrocyclic lactones. Caution must be exercised in breeds prone to the MDR1 (ABCB1) gene mutation, such as Collies, Australian Shepherds, and Shetland Sheepdogs. In these animals, the drug can cross the blood-brain barrier more easily, leading to severe neurotoxicity. It should not be administered to debilitated, underweight, or very young animals without specific veterinary oversight. Extra care is required in patients currently being treated with other CNS-depressant drugs or those with pre-existing hepatic or renal impairment, as metabolism and excretion may be altered.
Interactions
Known drug interactions include other macrocyclic lactones (like ivermectin or milbemycin oxime), as combined administration can increase the risk of neurotoxicity. Concurrent use of potent P-glycoprotein inhibitors, such as ketoconazole, itraconazole, or certain cyclosporine formulations, may elevate systemic levels of moxidectin in the blood, potentially increasing the risk of adverse neurological reactions. While it is often used alongside products like [Nitenpyram](/medications/nitenpyram-in-dogs-and-cats), [Indoxacarb](/medications/indoxacarb-in-dogs-and-cats), or [Pyriproxyfen](/medications/pyriproxyfen-in-dogs-and-cats), these combinations must only be attempted under the guidance of a licensed veterinarian to ensure safety profiles remain within acceptable limits for the individual patient.
Side Effects
- Ataxia (loss of coordination)
- Depression or lethargy
- Dilated pupils (mydriasis)
- Muscle tremors or twitching
- Hypersalivation or drooling
- Vomiting or diarrhea
- Seizures (in severe overdose or hypersensitive breeds)
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
